Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses

Chest

Volumn 118, Issue 6, 2000, Pages 1538-1546

  Affrime, Melton B ^a   Kosoglou, Teddy ^a   Thonoor, C Mohan ^a   Flannery, Brian E ^a   Herron, Jerry M ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Research Solutions LLC   (United States)

Author keywords

Cortisol; Fluticasone propionate; Hypothalamic pituitary adrenal axis; Inhaled glucocorticoids; Mometasone furoate; Prednisone; Safety; Systemic exposure

Indexed keywords

FLUTICASONE PROPIONATE; HYDROCORTISONE; MOMETASONE FUROATE; PREDNISONE; TETRACOSACTIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRY POWDER; FEMALE; FORCED EXPIRATORY VOLUME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

EID: 0034548064     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.118.6.1538     Document Type: Article

References (18)

1. Efficacy and safety of inhaled corticosteroids: New developments
2. Effect of inhaled corticosteroids on bones and growth
3. Clinical aspects of anti-inflammatory therapy in asthma
4. A comparison of the efficacy and safety of inhaled corticosteroids in asthma
5. The British guidelines on asthma management 1995 review and position statement: British Thoracic Society
6. A systemic bioactivity comparison of double-strength and regularstrength beclomethasone dipropionate MDI formulations
7. Dose-ranging study of a new steroid for asthma: Mometasone furoate dry powder inhaler
8. Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma
9. Glucocorticoids inhibit proliferation and interleukin-4 and interleukin-5 secretion by aeroallergen-specific T-helper type 2 cell lines
10. The inhibitory effects of topically active glucocorticoids on IL-4, IL-5, and interferon-γ production by cultured primary CD4+ T cells
11. In vitro glucocorticoid receptor binding and transcriptional activation by topically active glucocorticoids
12. Measures for detecting systemic bioactivity with inhaled and intranasal corticosteroids
13. Airway deposition and airway effects of antiasthma drugs delivered from metered-dose inhalers
14. Bioequivalent doses of budesonide and prednisone in moderate and severe asthma
15. Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axis
16. Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events